Comprehensive and Easily Searchable Databases Provide Information About Drugs
in All Stages of Development to Strengthen Patients' Medical Knowledge
HORSHAM, Pa., Sept. 4 /PRNewswire/ -- Acurian, a leader in accelerating
the launch of clinical trials for pharmaceutical and biotechnology companies,
today announced the launch of its Drug Knowledge Center (DKC), a set of
comprehensive databases providing accurate, consumer-friendly information
about drugs in all stages of development. This new resource complements
Acurian's existing clinical trial listings from both the government and
private sectors, the most extensive trial listings currently available online,
and the site's quality editorial content from sources like Johns Hopkins, The
FDC Reports and Engel Publishing.
Visitors to Acurian's Drug Knowledge Center can search for medications
currently being evaluated in U.S. clinical trials, as well as for drugs
already available in the U.S. The Drug Knowledge Center can be found at
http://www.acurian.com/diseases/drugs.
"Our Drug Knowledge Center represents a single reference point where
people can come to find accurate, easily understandable information regarding
both developmental and existing medications," said Faith Addiss, RN, Vice
President of Internet Strategy & Editorial at Acurian. "The DKC allows
individuals to learn more about the prescription medications they are taking,
research other drugs prescribed for their conditions, as well as peer into the
development pipeline -- without having to visit multiple sites that may or may
not have correct medical information."
In preparation for the launch of its new Drug Knowledge Center, Acurian
partnered with leading health information providers Gold Standard Multimedia
(GSM) and BioSpace, Inc. GSM's Clinical Pharmacology 2000 is the industry's
leading drug database, covering all U.S. prescription drugs, as well as over-
the-counter medications, herbal supplements, nutritional products, and new
drugs. Clinical Pharmacology 2000 is used in over 95 percent of U.S. medical
and pharmacy schools, and is the primary drug reference of three of the
nation's leading retail pharmacy chains. The GSM data includes clinical
information, product pictures and facts on drug precautions, interactions, use
and storage. Individuals can search the database by brand or generic drug
name, as well as by a specific medical condition. BioSpace's Clinical
Development Database compiles R&D activity from 700 biotechnology and
pharmaceutical companies covering nearly 4000 marketed and late stage
compounds and products.
"The new Drug Knowledge Center reflects Acurian's strategy to provide
comprehensive information about clinical trials and emerging treatment options
to millions of individuals worldwide," said Addiss. "Providing access to
relevant public and private clinical trials, and to information about existing
and new treatments, helps individuals get the trusted information they need
from a single source in order to make the most informed decisions about their
health."
About Acurian
Acurian is the leading provider of clinical trial patient and investigator
recruitment solutions for the pharmaceutical and biotechnology industries.
Acurian's proprietary databases enable these companies to identify qualified
physicians and patients for clinical trials, allowing new drug therapies to
reach patients more rapidly. To date, Acurian has worked with 40
pharmaceutical and biotechnology companies, including the seven largest in the
world, as well as with mid-sized and small pharmaceutical and biotech
companies. Acurian has already helped accelerate the launch of more than 60
clinical trials. With a seasoned management team, innovative technology
solutions, a Safe Harbor certification to serve clients in Europe and more
than $33 million in total funding from top technology and healthcare
investors, Acurian is poised for long-term success. Additional information
about Acurian is available at http://www.acurian.com.
About Gold Standard Multimedia
Gold Standard Multimedia (GSM), founded in 1993 and located in Tampa,
Florida, has been ranked by Deloitte & Touche as the third fastest-growing
technology company in Tampa Bay and number 235 out of 500 of the fastest-
growing technology companies in the nation. A publisher and developer of
innovative medical education and drug reference software and online services,
GSM's programs are used in over 95% of U.S. medical and pharmacy schools, as
well as by hundreds-of-thousands of healthcare professionals worldwide.
About BioSpace
BioSpace is a specialized provider of web-based products and information
services to the life sciences. The company's premier Website, http://www.biospace.com
is the Internet's most comprehensive life sciences-related information and
service resource, attracting 800,000 unique visitors and over 4 million page
views monthly. Recognizing the tidal wave of information that is engulfing the
industry as a result of rapid scientific advances, BioSpace has developed
products and services that more efficiently deliver relevant information to
the end user. Offered both on the Internet, or an enterprise Intranet,
BioSpace's suite of Enterprise Portal Services include BioSpace LInKS(TM)
technology, our Knowledge Management Solution, and Content Syndication of
clinical development information and industry news. Additionally the company
leverages its extensive online life sciences community to offer thousands of
job postings and widely recognized Career Fairs. BioSpace is a privately held,
venture capital backed company headquartered in San Francisco.
Contacts: David Restrepo, VP Business Development
Acurian
(215) 675-6100 Ext. 2605
david.restrepo@acurian.com
Press Contacts: Katherine Waite
The Portico Group
(781) 674-0216
kwaite@theporticogroup.com
Kristy Kozaka
The Portico Group
(781) 541-6506
kkozaka@theporticogroup.com
Acurian is a trademark of Acurian, Inc. All other names and terms are
trademarks or registered trademarks of their respective companies.
SOURCE Acurian
 back to top
Related links:
http://www.acurian.com
CONTACT:
David Restrepo, VP Business Development of
Acurian, +1-215-675-6100, Ext. 2605, david.restrepo@acurian.com;
or Katherine Waite, +1-781-674-0216, kwaite@theporticogroup.com,
or Kristy Kozaka, +1-781-541-6506, kkozaka@theporticogroup.com,
both of The Portico Group
|
